drugset / Trial / NCT02216253

L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract to Prevent Postoperative Urinary Tract Infection.

NCT02216253

Completed 150 enrolled IRCCS San Raffaele
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will include women who will undergo pelvic reconstructive surgery and/or anti-incontinence sling procedures. Patients will be randomized to the combination of L-methionine, Hibiscus Sabdariffa and Boswellia Leaf Extract in tablet or placebo twice a day during the seven days before and after surgery (total of 14 days). In this randomized, double-blind study, the investigators will assess treatment of clinically suspected or culture-proven urinary tract infections within 3 weeks of surgery (primary outcome), and risk factors for treatment for postoperative urinary tract infections (secondary outcomes) between the two study groups.

Timeline

Start
2014-10
Primary completion
2015-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Boswellia Leaf Extract Unknown
Comparator Hibiscus Sabdariffa Traditional medicine (herbal / TCM)
Comparator amino acids Unknown